It means the plan should be reviewed carefully by a physician who can evaluate risks, benefits, alternatives, monitoring needs, and whether another weight loss approach may be safer
The reason to remove them is accuracy, not safety
The IMCOSI trial demonstrated approximately 20% weight loss with the combination versus 16% with semaglutide alone over 48 weeks, though discontinuation rates were higher due to side effects
We prioritize products with certifications such as NSF Certified, Informed Sport, or similar independent verification ensuring accurate labeling, purity, and the absence of banned substances, which is crucial for both athletes and everyday users
More importantly, these modified GLP-1 analogues have shown hypoglycemic [185, 186] and cardiovascular protective effects [180, 183] in different animal models
Insulin secretion deficits in a Prader-Willi syndrome -cell model are associated with a concerted downregulation of multiple endoplasmic reticulum chaperones